
Microbot Medical Inc (MBOT.PH)  Company Profile | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Profile: Microbot Medical Inc (MBOT.PH)





Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				MBOT.PH on Philadelphia Stock Exchange


				1.28USD
28 Jul 2017





				    Change	(% chg)


		    
						    $0.09


					            (+7.56%)
					        






Prev Close

$1.19


Open

$1.33




Day's High

$1.33


Day's Low

$1.27




Volume

2,300


Avg. Vol

1,552




52-wk High

$25.20


52-wk Low

$1.08












					Full Description



Microbot Medical Inc., formerly StemCells, Inc., incorporated on August 2, 1988, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. The Company is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.The Company's ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. Its miniature dimensions allow it to navigate and crawl in different spaces within the human body, including blood vessels, the digestive tract and the respiratory system. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company's TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract.

» Full Overview of MBOT.PH







					Company Address



Microbot Medical Inc
175 Derby St # 27/1HINGHAM   MA   02043-4007
P: +1908.9385561F: +1302.6555049







					Company Web Links



Home Page








					Officers & Directors






Name
Compensation




							 Harel Gadot

--




							 David Ben Naim

--




							 Yehezkel Himelfarb

--




							 Yoseph Bornstein

--




							 Scott Burell

--




» More Officers & Directors





					Microbot Medical Inc News




BRIEF-Microbot Medical announces issuance of a Canadian patent covering a self-cleaning shunt

May 31 2017 
BRIEF-Microbot Medical reports Q1 loss per share $0.04

May 15 2017 
BRIEF-Microbot Medical files for mixed shelf of up to $75 mln

Mar 31 2017 
BRIEF-Microbot Medical appoints medical device veteran Martin Madden to board

Feb 07 2017 

» More MBOT.PH  News
















Related Topics: 
StocksStock ScreenerHealthcareBiotechnology & Medical Research





















Microbot Medical Inc (MBOT.OQ)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Microbot Medical Inc (MBOT.OQ)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				MBOT.OQ on NASDAQ Stock Exchange Capital Market


				1.30USD
28 Jul 2017





				    Change	(% chg)


		    
						    $0.08


					            (+6.56%)
					        






Prev Close

$1.22


Open

$1.25




Day's High

$1.34


Day's Low

$1.21




Volume

183,847


Avg. Vol

103,683




52-wk High

$26.91


52-wk Low

$1.08











					Summary





Name
Age
Since
Current Position




							Harel Gadot


2016

                                Chairman of the Board, President, Chief Executive Officer




							David Ben Naim

48
2016

                                Chief Financial Officer




							Yehezkel Himelfarb

59
2016

                                Chief Operating Officer, General Manager - Israeli Operations




							Yoseph Bornstein


2016

                                Director




							Scott Burell

51
2016

                                Director




							Solomon Mayer

62
2016

                                Director




							Moshe Shoham

65
2016

                                Director




							Yoav Waizer


2016

                                Director




							Martin Madden

56
2017

                                Independent Director



» Insider Trading





					Biographies





Name
Description




							Harel Gadot


					
							Mr. Harel Gadot serves as Chairman of the Board, President, Chief Executive Officer of the Company. He is a co-founder of Microbot Israel and has served as Chief Executive Officer since Microbot Israel was founded in November 2010. He has been the Chairman of Microbot Israel’s Board of Directors since July 2014. He also serves as the Chairman of XACT Robotics Ltd. since August 2013 and MEDX Xelerator LP since July 2016. From December 2007 to April 2010 Mr. Gadot was a Worldwide Group Marketing Director at Ethicon Inc., a Johnson and Johnson Company, where he was responsible for the global strategic marketing of the company. Mr. Gadot also held management positions, as well as leading regional strategic position for Europe, Middle-East and Africa, as well as in Israel, while at Johnson and Johnson. Mr. Gadot served as director for ConTIPI Ltd. from August 2010 until November 2013 when ConTIPI Ltd. was acquired by Kimberly-Clark Corporation. Mr. Gadot holds a B.Sc.in Business from Siena College, Loudonville NY, and an M.B.A. from the University of Manchester, UK.




							David Ben Naim


					
							Mr. David Ben Naim serves as Chief Financial Officer of the Company. He is the general manager of DBN Finance Services Ltd., a company which provides outsourcing financial services to public and private companies, since 2014. Through DBN Finance Services, Mr. Ben Naim has acted as the outsourced CFO for Emerald Medical Applications Corp. (OTC:MRLA), a digital health startup company engaged in the development, sale and service of imaging solutions, and Tempramed Inc., a private medical device company. Prior to that, Mr. Ben Naim served as Chief Financial Officer for several companies in the biomedical and technology industries. From July 2012 to September 2014, Mr. Ben Naim served as Chief Financial Officer for Insuline Medical Ltd. (TASE: INSL), an Israel-based company focused on improving performance of insulin treatment methods. From 2008 until 2011, Mr. Ben Naim served as Chief Financial Officer of Crow Technologies 1977 Ltd. (OTC:CRWTF), a company that designs, develops, manufactures and sells a broad range of security and alarm systems. From 2007 to 2008, Mr. Ben Naim served as Chief Financial Officer of Ilex Medical Ltd. (TASE:ILX), a leading company in the medical diagnostics field. From 2003 to 2007, Mr. Ben Naim was the Corporate Controller of Tadiran Telecom Ltd. He started his career in 1998 at Deloitte & Touche where he left in 2003 as an Audit Senior Manager. Mr. Ben Naim holds a B.A. in social sciences from Open University, Israel, a CPA license from Ramat Gan College, Israel, and an M.B.A. from Ono Academic College, Israel.




							Yehezkel Himelfarb


					
							Mr. Yehezkel Himelfarb serves as Chief Operating Officer, General Manager - Israeli Operations of the Company. Mr. Himelfarb was the Chief Executive Officer from 2008 through November 2016 and a member of the board of directors from 2008 through August 2016 of IceCure Medical Ltd., Tel Aviv Stock Exchange listed company that develops advanced cryotherapy systems (cryoablation) intended for the growing physician-office market. Prior to that, from 1999 to 2008, Mr. Himelfarb was the President, Chief Executive Officer and a member of the board of directors of Remon Medical Technologies, Inc., a venture backed US/Israeli company that developed and commercialized smart, miniature implants which enabled physicians to assess and treat a variety of medical conditions, where he, among other things, led its acquisition by Boston Scientific. From 1996 to 1999, he was the Vice President and Chief Operating Officer of Medtronic-InStent (Israel), which was part of Medtronic’s vascular division. From 1982 to 1996, Mr. Himelfarb had various positions at Scitex Corporation Ltd., which was an Israeli-based company specializing in specialty equipment production. Mr. Himelfarb holds a B.Sc. in Electronic Engineering and an M.B.A. in Marketing and Engineering Management, both from Tel Aviv University.




							Yoseph Bornstein


					
							Mr. Yoseph Bornstein serves as Director of the Company. He is a co-founder of Microbot Israel and has been a member of the Board of Directors since Microbot Israel was founded in November 2010. Mr. Bornstein founded Shizim Ltd., a life science holding group in October 2000 and has served as its president since then. Mr. Bornstein is the Chairman of GCP Clinical Studies Ltd., a provider of clinical research services and educational programs in Israel since January 2002. He is the Chairman of Biotis Ltd., a service company for the bio-pharmaceutical industry, since June 2000. In addition, he is the Chairman of Dolphin Medical Ltd., a service company for the medical device industry, since April 2012 and the Chairman of ASIS Enterprises B.B.G. Ltd., a business August 2007. In October 1992, Mr. Bornstein founded Pharmateam Ltd., an Israeli company that specialized in representing international pharmaceutical companies which was sold in 2000. Mr. Bornstein is also a founder of a number of other privately held life-science companies. Mr. Bornstein served as the Biotechnology Committee Chairman of the Unites States-Israel Science & Technology Commission (the “USISTF”) from September 2002 to February 2005 as well as a consultant for USISTF from September 2002 to February 2005. He is also the founder of ILSI-Israel Life Science Industry Organization and ITTN-Israel Tech Transfer Organization.




							Scott Burell


					
							Mr. Scott R. Burell serves as Director of the Company. He has served as a member of the Board of Directors of Microbot Israel since the closing of the Merger on November 28, 2016. He is the Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation, a family health-focused clinical molecular diagnostic laboratory specializing in pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders, since November 2006. He successfully led the split-off of CombiMatrix in 2007 from its former parent, has led several successful public and private debt and equity financing transactions as well as CombiMatrix’s reorganization in 2010. Prior to this, Mr. Burell had served as CombiMatrix’s Vice President of Finance since November 2001 and as its Controller from February 2001 to November 2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell was the Controller for Network Commerce, Inc., a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent 9 years with Arthur Andersen’s Audit and Business Advisory practice in Seattle. During his tenure in public accounting, Mr. Burell worked with many clients, both public and private, in the high-tech and healthcare markets, and was involved in numerous public offerings, spin-offs, mergers and acquisitions. Mr. Burell obtained his Washington state CPA license in 1992 and is a certified public accountant (currently inactive). He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University.




							Solomon Mayer


					
							Mr. Solomon Mayer serves as Director of the Company. He has served as a member of the Board of Directors of Microbot Israel since June 2014, as the designated director of Alpha Capital. Mr. Mayer has served as the President and Chief Executive Officer of Mooney Aviation Company since June 1999. He also serves as President of Chailife Line, an organization devoted to help restore normalcy to family life and better enable them to withstand the crises and challenges of serious pediatric illness. In addition, Mr. Mayer serves as a Director of the Laniado Hospital, International Medical Search Co. of New York, Blastgard International, Inc. and Ironwood Gold Corp.




							Moshe Shoham


					
							Dr. Moshe Shoham, D.Sc., serves as Director of the Company. He is a co-founder of Microbot Israel and has served as Chairman of Microbot Israel’s Scientific Advisor Board and as a Director since Microbot Israel was founded in November 2010. Prof. Shoham has been the head of the robotics laboratory at the Technion-Israel Institute of Technology, Department of Mechanical Engineering since October 1990 and has been a professor in the Department of Mechanical Engineering at the Technion-Israel Institute of Technology since October 1989. Prior to that, Dr. Shoham was the director of the robotic laboratory in the Department of Mechanical Engineering at Columbia University from September 1986 to September 1989. Dr. Shoham has served as a foreign member of the National Academy of Engineering in the United States since October 2014. In addition, Dr. Shoham founded Mazor Surgical Technologies Ltd., a publically traded medical device company in the field of surgical robotics, and has been its Chief Technology Officer since January 2003. Dr. Shoham earned B.Sc. in 1978, a M.Sc. in 1982 and a D.Sc. in 1986 from the Technion-Israel Institute of Technology.




							Yoav Waizer


					
							Mr. Yoav Zvi Waizer serves as Director of the Company. He has served as a member of the Board of Directors of Microbot Israel since May 2015. Mr. Waizer is a Partner and Chief Executive Officer of Medica Venture Partners, a healthcare dedicated venture investing out of Israel in innovative capital-starved early stage and special situation companies, since November 2005. Prior to his Tenure at Medica, Mr. Waizer served as CFO & COO at Cedar Fund, a venture capital fund focuses on investing in Israel-related high-tech companies in the telecom, networking, Internet-infrastructure and enterprise software areas and prior to that Mr. Waizer was the CFO of Star Ventures Israel, the Israeli fund of Star Ventures, a $1 billion venture capital fund investing in all stages of development within the Telecom, Enterprise S/W, Wireless and Life Sciences sectors. Mr. Waizer is currently a director of InterCure Ltd., a company focused on investing in medical technology companies that is traded on the Tel Aviv Stock exchange. Mr. Waizer holds Master of Business Administration in Information Systems and B.Sc. in Accounting and Statistics, both from the Tel-Aviv University.




							Martin Madden


					
							Mr. Martin J. Madden serves as Independent Director of the Company. Mr. Madden has held various positions at Johnson & Johnson and its affiliates from 1986 to January 2017, most recently as Vice President, Research & Development of DePuy Synthes, a Johnson & Johnson Company, from February 2016 to January 2017. Prior to that, from July 2015 to February 2016, Mr. Madden was the Vice President, New Product Development of Johnson & Johnson Medical Devices. From January 2012 to July 2015, Mr. Madden was the Vice President, Research & Development of Johnson & Johnson’s Global Surgery Group. Mr. Madden holds a MBA from Columbia University, a M.S. from Carnegie Mellon University in Mechanical Engineering, and a B.S. from the University of Dayton in Mechanical Engineering.











					Basic Compensation





Name
Fiscal Year Total




							Harel Gadot

--




							David Ben Naim

--




							Yehezkel Himelfarb

--




							Yoseph Bornstein

--




							Scott Burell

--




							Solomon Mayer

--




							Moshe Shoham

--




							Yoav Waizer

--




							Martin Madden

--



As Of 






					Options Compensation





Name
Options
Value




							Harel Gadot

0
0




							David Ben Naim

0
0




							Yehezkel Himelfarb

0
0




							Yoseph Bornstein

0
0




							Scott Burell

0
0




							Solomon Mayer

0
0




							Moshe Shoham

0
0




							Yoav Waizer

0
0




							Martin Madden

0
0









					Insider Trading












Name
Shares Traded
Price


Lewkowicz (Leon)
71,224
$1.67


Alpha Capital Anstalt
9,753,549
$0.00


Alpha Capital Anstalt
7,977,092
$0.00


Stratton (Kenneth Blair J.D.)
5,834
$2.92


Koshy George
2,084
$2.92


Weissman (Irving L)
48,077
$0.00


Schiffman (Gregory T)
720,000
$0.00


Massey (Ian J)
378,460
$0.00


Schiffman (Gregory T)
166,000
$0.30


Stratton (Kenneth Blair J.D.)
14,228
$0.35


Koshy George
4,378
$0.35


Massey (Ian J)
1,250,000
$0.00


Koshy George
28,457
$0.38


Stratton (Kenneth Blair J.D.)
35,024
$0.38


Schiffman (Gregory T)
25,976
$0.38


McGlynn (Martin M)
236,736
$0.38


Weissman (Irving L)
29,762
$0.00


Weissman (Irving L)
146,342
$0.00


Schwartz (John J)
146,342
$0.00


Bjerkholt (Eric H)
146,342
$0.00


Levy (Ricardo B)
146,342
$0.00


Trounson (Alan O)
146,342
$0.00


Schiffman (Gregory T)
38,307
$0.42


Greer (R Scott)
146,342
$0.00


Stratton (Kenneth Blair J.D.)
104,549
$0.45




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research






















Berkson Avram - profile of CEO, director, businessman





















BizPedia.xyz  - We monitor changes in companies
 






Berkson Avram  - profile of CEO, director, businessman


FREE EMAIL WATCHDOG
Get free email notifications about news for Berkson Avram.










The service is free and you can unsubscribe at any time.

Berkson Avram - Check out list of companies related to Berkson Avram. Find out people related to Berkson Avram - coworkers / colleagues / companions.
Address: C/O SABER HOLDING GMBH  WIEN KRUMMBAUMGASSE 1020 Austria  







Companies related to Berkson Avram
CIKNameStateCIKIRSStock0000883975Microbot Medical Inc.Delaware0000883975943078125STEM



People related to Berkson Avram, company Microbot Medical Inc.NameCityCountryALPHA CAPITAL AKTIENGESELLSCHAFTVADUZ LIECHTENSTEINAustriaBerkson SandraWIEN KRUMMBAUMGASSEAustriaBJERKHOLT ERICPALO ALTOCABJERKHOLT ERICNEWARKCABornstein YosephYOKNEAMIsraelBurell Scott RMUKILTEO,WACRAIG STEWARTPALO ALTOCACRAIG STEWARTNEWARKCADavid NaimHolonIsraelGadot HarelYOKNEAMIsraelGREER R SCOTTGREER R SCOTTPALO ALTOCAHarel GadotHinghamMAHimelfarb YehezkelYOKNEAMIsraelKOSHY GEORGEPALO ALTOCAKOSHY GEORGENEWARKCALEVY RICARDO BLEVY RICARDO BNEWARKCALEVY RICARDO BPALO ALTOCALewkowicz LeonYOKNEAMIsraelLum Judi RPALO ALTOCAMadden Martin J.HINGHAMMAMassey Ian JVANCOUVERA1MCGLYNN MARTIN MPALO ALTOCAMCGLYNN MARTIN MNEWARKCAMoshe ShohamHoshaya M.P. HamovilIsraelNaim David BenYOKNEAMIsraelOCONNELL DESMOND H JRPALO ALTOCAPERLMUTTER ROGER MPALO ALTOCAPERLMUTTER ROGER MNEWARKCASalinas Eliseo OresteNEWARKCASCHIFFMAN GREGORY TNEWARKCASCHIFFMAN GREOGRY TMOUNTAIN VIEWCASCHWARTZ JOHN JPALO ALTOCASCHWARTZ JOHN JNEWARKCAScott BurellIrvineCAShoham MosheYOKNEAMIsraelSolomon MayerYOKNEAMIsraelSolomon MayerBrooklynNYStratton Kenneth BlairPALO ALTOCAStratton Kenneth BlairNEWARKCATrounson Alan ONEWARKCATSUKAMOTO ANNPALO ALTOCATSUKAMOTO ANNNEWARKCAWaizer Yoav ZviYOKNEAMIsraelWEISSMAN IRVINGPALO ALTOCAWEISSMAN IRVINGNEWARKCAYehezkel HimelfarbTel-AvivIsraelYoav WaizerRa'ananaIsraelYoseph BornsteinRosh-HaayinIsraelYoung Rodney KBPALO ALTOCAYoung Rodney KBNEWARKCA

















Yehezkel  Himelfarb - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Yehezkel  Himelfarb
Check out list of companies and businesses related to Yehezkel  Himelfarb. Find out Yehezkel  Himelfarb address and contact details. View other people related to Yehezkel  Himelfarb - coworkers, colleagues, companions, etc.
Address:   

C/O MICROBOT MEDICAL INC. 5 HAMADA STREET YOKNEAM 20692 Israel




Companies related to Yehezkel  Himelfarb
CIKCompany NamePositionCompany Address0000883975Microbot Medical Inc.175 DERBY ST. 27/1 . HINGHAM 02043




Yehezkel  Himelfarb on the Web
Persons related to Yehezkel  Himelfarb - Microbot Medical Inc.NamePositionCityCAPITAL AKTIENGESELLSCHAFT  ALPHA10% Owner VADUZ LIECHTENSTEINAvram  BerksonWIEN KRUMMBAUMGASSESandra  BerksonWIEN KRUMMBAUMGASSEERIC  BJERKHOLTDirector PALO ALTOERIC  BJERKHOLTDirector NEWARKYoseph  BornsteinYOKNEAMScott R  BurellMUKILTEO,STEWART  CRAIGSVP, Development & Operations PALO ALTOSTEWART  CRAIGSVP, Development & Operations NEWARKNaim  DavidHolonHarel  GadotYOKNEAMR SCOTT  GREERDirector R SCOTT  GREERDirector PALO ALTOGadot  HarelHinghamYehezkel  HimelfarbYOKNEAMGEORGE  KOSHY PALO ALTOGEORGE  KOSHY NEWARKRICARDO B  LEVYDirector RICARDO B  LEVYDirector NEWARKRICARDO B  LEVYDirector PALO ALTOLeon  Lewkowicz10% Owner YOKNEAMJudi R  LumCFO PALO ALTOMartin J.  MaddenHINGHAMIan J  MasseyChief Executive Officer VANCOUVERMARTIN M  MCGLYNNPresident & CEO PALO ALTOMARTIN M  MCGLYNNPresident & CEO NEWARKShoham  MosheHoshaya M.P. HamovilDavid Ben  NaimYOKNEAMDESMOND H  OCONNELL JRDirector PALO ALTOROGER M  PERLMUTTERDirector PALO ALTOROGER M  PERLMUTTERDirector NEWARKEliseo Oreste  SalinasEVP and Head of R&D NEWARKGREGORY T  SCHIFFMANChief Financial Officer NEWARKGREOGRY T  SCHIFFMANChief Financial Officer MOUNTAIN VIEWJOHN J  SCHWARTZDirector PALO ALTOJOHN J  SCHWARTZDirector NEWARKBurell  ScottIrvineMoshe  ShohamYOKNEAMMayer  SolomonYOKNEAMMayer  SolomonBrooklynKenneth Blair  StrattonGeneral Counsel PALO ALTOKenneth Blair  StrattonGeneral Counsel NEWARKAlan O  TrounsonDirector NEWARKANN  TSUKAMOTOEVP, Research and Development PALO ALTOANN  TSUKAMOTOEVP, Research and Development NEWARKYoav Zvi  WaizerYOKNEAMIRVING  WEISSMANDirector PALO ALTOIRVING  WEISSMANDirector NEWARKHimelfarb  YehezkelTel-AvivWaizer  YoavRa'ananaBornstein  YosephRosh-HaayinRodney KB  YoungCFO PALO ALTORodney KB  YoungCFO NEWARK
Potentially same personNameCityCountryHimelfarb  YehezkelCaesareaIsraelHimelfarb  YehezkelTel-AvivIsrael












 








Himelfarb  Yehezkel - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Himelfarb  Yehezkel
Check out list of companies and businesses related to Himelfarb  Yehezkel. Find out Himelfarb  Yehezkel address and contact details. View other people related to Himelfarb  Yehezkel - coworkers, colleagues, companions, etc.
Address:   

32 Ben Yosef Street  Tel-Aviv 6912530 Israel




Companies related to Himelfarb  Yehezkel
CIKCompany NamePositionCompany Address0000883975Microbot Medical Inc.175 DERBY ST. 27/1 . HINGHAM 02043




Himelfarb  Yehezkel on the Web
Persons related to Himelfarb  Yehezkel - Microbot Medical Inc.NamePositionCityCAPITAL AKTIENGESELLSCHAFT  ALPHA10% Owner VADUZ LIECHTENSTEINAvram  BerksonWIEN KRUMMBAUMGASSESandra  BerksonWIEN KRUMMBAUMGASSEERIC  BJERKHOLTDirector PALO ALTOERIC  BJERKHOLTDirector NEWARKYoseph  BornsteinYOKNEAMScott R  BurellMUKILTEO,STEWART  CRAIGSVP, Development & Operations PALO ALTOSTEWART  CRAIGSVP, Development & Operations NEWARKNaim  DavidHolonHarel  GadotYOKNEAMR SCOTT  GREERDirector R SCOTT  GREERDirector PALO ALTOGadot  HarelHinghamYehezkel  HimelfarbYOKNEAMGEORGE  KOSHY PALO ALTOGEORGE  KOSHY NEWARKRICARDO B  LEVYDirector RICARDO B  LEVYDirector NEWARKRICARDO B  LEVYDirector PALO ALTOLeon  Lewkowicz10% Owner YOKNEAMJudi R  LumCFO PALO ALTOMartin J.  MaddenHINGHAMIan J  MasseyChief Executive Officer VANCOUVERMARTIN M  MCGLYNNPresident & CEO PALO ALTOMARTIN M  MCGLYNNPresident & CEO NEWARKShoham  MosheHoshaya M.P. HamovilDavid Ben  NaimYOKNEAMDESMOND H  OCONNELL JRDirector PALO ALTOROGER M  PERLMUTTERDirector PALO ALTOROGER M  PERLMUTTERDirector NEWARKEliseo Oreste  SalinasEVP and Head of R&D NEWARKGREGORY T  SCHIFFMANChief Financial Officer NEWARKGREOGRY T  SCHIFFMANChief Financial Officer MOUNTAIN VIEWJOHN J  SCHWARTZDirector PALO ALTOJOHN J  SCHWARTZDirector NEWARKBurell  ScottIrvineMoshe  ShohamYOKNEAMMayer  SolomonYOKNEAMMayer  SolomonBrooklynKenneth Blair  StrattonGeneral Counsel PALO ALTOKenneth Blair  StrattonGeneral Counsel NEWARKAlan O  TrounsonDirector NEWARKANN  TSUKAMOTOEVP, Research and Development PALO ALTOANN  TSUKAMOTOEVP, Research and Development NEWARKYoav Zvi  WaizerYOKNEAMIRVING  WEISSMANDirector PALO ALTOIRVING  WEISSMANDirector NEWARKHimelfarb  YehezkelTel-AvivWaizer  YoavRa'ananaBornstein  YosephRosh-HaayinRodney KB  YoungCFO PALO ALTORodney KB  YoungCFO NEWARK
Potentially same personNameCityCountryHimelfarb  YehezkelCaesareaIsraelYehezkel  HimelfarbYOKNEAMIsrael




Other people with surname HimelfarbHimelfarb  Matthew, Himelfarb  Matt, Himelfarb  Robert, Himelfarb  Matt, Himelfarb  Richard








 








Yehezkel Himelfarb, MBA - Biography

















































































Log in






E-mail



Password







Remember




Forgot password ?









Become a member for free
Sign up





Sign up




New memberSign up for FREE


New customerDiscover our portfolios












 United States
 United Kingdom
 France
 Deutschland
 Schweiz (DE)
 Suisse (FR)










Settings

            Dynamic quotes 


OFFON

















Markets
Equities
North AmericaEuropeAsiaOceaniaMiddle East» More Equities

Indexes
DOW JONESS&P 500NASDAQ 100TSX COMPFTSE 100» More Indexes

Currency / Forex
EUR / USDGBP / USDUSD / JPYUSD / CADAUD / USD» More Currencies

Commodities
GOLDCrude Oil (WTI)Crude Oil (BRENT)SILVERPLATINUM» More Commodities


 News
Latest News
CompaniesMarketsEconomyCurrency / ForexCommoditiesInterest RatesBusiness LeadersFinancial calendarEconomic calendar

Listed company
Analyst reco.RumorsIPOsCapital Markets TransactionsNew ContractsProfits warningsAppointmentsPress ReleasesEventsCorporate actions

Sector News
EnergyBasic MaterialsIndustrialsConsumer CyclicalConsumer Non-CyclicalFinancialsHealthcareTechnologyTelecommunications ServicesUtilities


 Analysis
All AnalysisCommentariesIndex AnalysisStock Trading StrategiesCommodity AnalysisForex Analysis

 Stock Picks
All stock picks

 Portfolios
My Portfolio
Virtual portfolios
4-Traders Portfolios
European PortfolioUSA PortfolioAsian Portfolio


 Screeners
Market Screener HomeFundamental Analyse
Top Investor RatingTop Trading RatingTop ConsensusGrowth stocksYield stocksLow valuations

Technical Analysis
Oversold stocksOverbought stocksClose to resistancesClose to supportsAccumulation phaseMost volatile stocks


 Watchlists
My Watchlists
Watchlists
Top Lists
Yield stocksGrowth stocksUndervalued Stocks


 Top / Flop
Top News
Most Read NewsHot News

Top Fundamentals
Top CapitalizationTop YieldTop PERTop ConsensusTop Fundamentals

Top Technicals
Top RSIUnusual volumesTop GapsTop STIM

Top Movers
Top USATop CanadaTop U.K.Top GermanyTop EuropeTop Asia


 Tools
Market ScreenerDynamic chartFinancial calendarEconomic calendarSector researchCurrency converter

 Our Services
Premium AccessDiscover our Services

 



















 






4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography


Business Leaders




Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors HomeAll newsMost read newsBusiness Leaders Biography


 
















Yehezkel Himelfarb, MBA

Age : 60Linked companies :  Microbot Medical Inc 





Summary 



Mr. Yehezkel Himelfarb is Chief Operating Officer & General Manager at Microbot Medical, Inc. Mr. Himelfarb was previously employed as Chief Executive Officer & Director by IceCure Medical Ltd., a Principal by Medtronic Instent, Inc., Chief Executive Officer by Remon Medical Technologies, Inc., and a Principal by Suny Cellular Communication Ltd.He received his undergraduate degree from Tel-Aviv University and an MBA from Tel-Aviv University.



Current positions of Yehezkel Himelfarb, MBA 









 NameTitle
Since
 Microbot Medical Inc(Biotechnology & Medical Research)
Chief Operating Officer & General Manager
2016



Yehezkel Himelfarb, MBA: Personal Network 







 NameLinked companies

Scott R. Burell Microbot Medical Inc 

Moshe Shoham Microbot Medical Inc 

Yoav Waizer Microbot Medical Inc 

Solomon Mayer Microbot Medical Inc 

David Ben Naim Microbot Medical Inc 

Harel Gadot Microbot Medical Inc 

Yossi Bornstein Microbot Medical Inc 

Eyal Ben-Moshe Microbot Medical Inc 

Ahava Stein Microbot Medical Inc 

Martin J. Madden Microbot Medical Inc 




Most Read News 




07/27 LI KA-SHING : Li Ka-shing's CKI to buy German energy metering firm Ista



07/26DJBERNARD ARNAULT : LVMH's Profit Rises 24% in First Half



07/27 RUPERT MURDOCH : As Murdoch waits, Sky cuts operating costs to protect profits



07/26DJMEG WHITMAN : Meg Whitman Steps Down From HP Board



07/28DJNELSON PELTZ : Procter & Gamble, Peltz Spar on Results -- WSJ



07/28 CARLOS SLIM : Hutchison's Drei buys Tele2 to rival Carlos Slim in Austria



07/26DJDAVID SIMON : Executive Pay Falls for Big Mall Owners as Retail Storm Rages On



07/27DJJEFF BEZOS : Amazon's Jeff Bezos Becomes World's Richest Person



07/28DJELON MUSK : Top Company News of the Day



07/22DJWILBUR ROSS : More Cross-Border Commerce



More news

 


            © 2017 People and Ownership :    









Advertisement








Yehezkel Himelfarb, MBA : Connections 



 AgEagle Aerial Systems Inc









Scott R. Burell




 Microbot Medical Inc









Scott R. BurellMoshe ShohamYoav WaizerSolomon MayerDavid Ben NaimHarel GadotYossi BornsteinEyal Ben-MosheAhava SteinMartin J. Madden




 CombiMatrix Corp









Scott R. Burell




 Novocure Ltd









Martin J. Madden




 Ironwood Gold Corp









Solomon Mayer




 BlastGard International Inc.









Solomon Mayer




 Mazor Robotics Ltd









Moshe Shoham




 Vonetize Plc









David Ben Naim




 InterCure Ltd









Yoav Waizer




Fixtures 2000, Inc.
                                            








Solomon Mayer





XACT Robotics Ltd.
                                            








Moshe ShohamHarel GadotYossi Bornstein





Medica Venture Partners
                                            








Yoav Waizer





The American Institute of Certified Public Accountants
                                            








Scott R. Burell





Chai Lifeline, Inc.
                                            








Solomon Mayer





Ditto Consultants Ltd.
                                            








Yoav Waizer





Shizim Ltd.
                                            








Yossi Bornstein





Laniado Hospital
                                            








Solomon Mayer





National Academy of Engineering
                                            








Moshe Shoham





Orange County Chapter
                                            








Scott R. Burell





Supreme Construction & Development Corp.
                                            








Solomon Mayer





 







Popular Business Leaders 


 

Bernard Arnault
Mary Barra
Luc Besson
Jeff Bezos
Lloyd Blankfein
Michael Bloomberg
Yannick Bolloré
Warren Buffett
Jean-paul Clozel
Gary Cohn
Marc De Lacharrière
Jamie Dimon
Ralph Dommermuth
Sebastian Ebel
John Edwards
David Einhorn
Jeff Fettig
Mark Fields
Carlos Ghosn
David Henry
Carl Icahn
Li Ka-shing
Michel Landel
Daniel Loeb
Jack Ma
Lakshmi Mittal
Rupert Murdoch
Elon Musk
Peter Nicholas
Xavier Niel
John Paulson
Nelson Peltz
Georges Plassat
Hasso Plattner
Thomas Rabe
Giuseppe Recchi
Wolfgang Reitzle
Wilbur Ross
Charles Schwab
Igor Sechin
Carlos Slim
Pascal Soriot
George Soros
Rupert Stadler
Bernard Tapie
John Williamson
Thomas Wilson
Dieter Zetsche
Mark Zuckerberg



A-Z Business Leaders




 



























4-traders.com :MarketsNewsAnalysisStock PicksPortfoliosScreenersWatchlistsTop / FlopToolsOur ServicesAbout :Surperformance SASContact usAdvertiseLegal informationsAbout usStay Connected :FacebookTwitterPartners :Börse: Aktien, Kurse und NachrichtenBest tweets 




   Copyright © 2017 Surperformance. All rights reserved.  












 














Master







Microbot Medical Inc.: Private Company Information - Bloomberg









































  





















































































July 29, 2017 12:06 AM ET
Healthcare Equipment and Supplies

Company Overview of Microbot Medical Inc.



Snapshot People




Company Overview
Microbot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company’s product candidates include Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and TipCAT, a semi-disposable, flexible, and self-propelled endoscope for use in colonoscopy procedures, as well as ViRob, a revolutionary autonomous crawling micro-robot technology, which can be controlled remotely or within the body. Microbot Medical Inc. was founded in 2010 and is based in Yokneam, Israel.


5 Hamada StreetYokneam,  2069204IsraelFounded in 20106 Employees



Phone: 908 9 385561

Fax: 972 4 8200712

www.microbotmedical.com







Key Executives for Microbot Medical Inc.




Mr. Harel Gadot


      	Co-Founder, Chairman, Chief Executive Officer and President
      


Age: 44
        

Total Annual Compensation: $275.0K








Mr. David Ben Naim


      	Chief Financial Officer
      


Age: 48
        

Total Annual Compensation: $6.0K








Mr. Yehezkel Himelfarb BSc, MBA


      	Chief Operating Officer and General Manager
      


Age: 59
        

Total Annual Compensation: $16.0K





Compensation as of Fiscal Year 2016. 

Microbot Medical Inc. Key Developments

Microbot Mulls Acquisitions
Jun 5 17
Microbot Medical Inc. (NasdaqCM:MBOT) is looking for acquisition opportunities. Microbot announced today that it has entered into a securities purchase agreement with three institutional investors to purchase 3.75 million shares of common stock for total gross proceeds of $10.125 million, before deducting placement agent fees and offering expenses. Microbot expects to use the resources from the financing to expand and leverage the current ViRob and TipCAT technology platforms, for potential strategic partnerships and acquisition of assets, products or entities, and for general corporate and working capital purposes.


Microbot Medical Inc. Announces Unaudited Consolidated Earnings Results for the Quarter Ended March 31, 2017
May 15 17
Microbot Medical Inc. announced unaudited consolidated earnings results for the quarter ended March 31, 2017. For the quarter, the company operating loss of USD 1,233,000 against USD 285,000 a year ago. Net loss was USD 1,307,000 or USD 0.04 basic and diluted loss per share against USD 276,000 or USD 0.01 basic and diluted loss per share a year ago.


Microbot Medical Seeks Acquisition
Mar 31 17
Microbot Medical Inc. (NasdaqCM:MBOT) has filed a Shelf Registration in the amount of $75 million. Microbot in its prospectus stated-"We cannot assure you that we will receive any proceeds in connection with securities which may be offered pursuant to this prospectus. Unless otherwise indicated in the applicable prospectus supplement, we intend to use any net proceeds from the sale of securities under this prospectus for our operations, our further development and commercialization of our product candidates, and other general corporate purposes, which may include, but are not limited to, working capital, intellectual property protection and enforcement, capital expenditures, repayment of indebtedness, investments, acquisitions and collaborations."


Similar Private Companies By Industry



Company Name
Region



 2P2D Solutions Ltd. Middle East/Africa A.B. Dental Devices, Limited Middle East/Africa ActiVein Inc. Middle East/Africa Acuity Ltd. Middle East/Africa ADM  Advanced Dialysis Methods Ltd. Middle East/Africa




Recent Private Companies Transactions



TypeDate
Target





Merger/Acquisition

			      August 15, 2016
			    
StemCells Inc.





Request Profile Update

















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



Most Searched Private Companies



Company Name
Geographic Region



 Lawyers Committee for Civil Rights Under Law United States NYC2012, Inc. United States The Advertising Council, Inc. United States Bertelsmann AG Europe Rush University United States













Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Microbot Medical Inc., please visit www.microbotmedical.com.  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























 SECGems: Microbot Medical Inc.  [ MBOT ] 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 Microbot Medical Inc. 
		     
 [  NASDAQ ]
 [ MBOT ]










 Info




 Ownership




 Filings
902













	 
	
	 175 DERBY ST. 27/1
	 
	  .
	
	   HINGHAM, 
	   MA, 
	  
	
	  
		
		

			
			 
		
		
		
		 USA
		
	
	   908-938-5561    
	    

						        









Filing DateCurrent and former namesChanged on date




2016-11-29Microbot Medical Inc.


2015-06-15STEMCELLS INC


2000-05-31CYTOTHERAPEUTICS INC/DE1993-03-28








Central Index Key (CIK)
0000883975
State of Incorporation
DE
Country of Incorporation
USA
Fiscal year end
1231
IRS #
943078125
Std. Industrial Class.
2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)










Ownership (Form 3,4,5)# Filings





 ALPHA CAPITAL ANSTALT (0001140358) 


1




 BJERKHOLT ERIC (0001197350) 


15




 Berkson Avram (0001690753) 


1




 Berkson Sandra (0001690757) 


1




 Bornstein Yoseph (0001690100) 


1




 Burell Scott R (0001399318) 


1




 CRAIG STEWART (0001282810) 


15




 ENGLANDER ISRAEL A (0001017456) 


11




 GREER R SCOTT (0001211703) 


7




 Gadot Harel (0001690103) 


1




 Himelfarb Yehezkel (0001689912) 


1




 KOSHY GEORGE (0001257780) 


49




 LEVY RICARDO B (0000942916) 


18




 Lewkowicz Leon (0001690590) 


2




 Lum Judi R (0001308210) 


5




 MCGLYNN MARTIN M (0001230631) 


41




 MILLENNIUM HOLDING GROUP LP (0001273089) 


11




 MILLENNIUM MANAGEMENT LLC (0001273087) 


11




 Madden Martin J (0001696864) 


1




 Massey Ian J (0001379281) 


4




 Naim David Ben (0001692130) 


1




 OCONNELL DESMOND H JR (0001193615) 


4




 PERLMUTTER ROGER M (0001184228) 


13




 RIVERVIEW GROUP LLC (0001273091) 


11




 SCHIFFMAN GREGORY T (0001239011) 


8




 SCHWARTZ JOHN J (0001230629) 


23




 Salinas Eliseo Oreste (0001435756) 


2




 Shoham Moshe (0001690161) 


1




 Solomon Mayer (0001689854) 


1




 Stratton Kenneth Blair (0001461320) 


27




 TSUKAMOTO ANN (0001230632) 


42




 Trounson Alan O (0001618467) 


4




 WEISSMAN IRVING (0001230630) 


44




 Waizer Yoav Zvi (0001689845) 


1




 Young Rodney KB (0001337831) 


21











Form D Related Persons# Filings





 David Ben Naim (0001692130) 


1




 Harel Gadot (0001690103) 


1




 Moshe Shoham (0001690161) 


1




 Scott R Burell (0001399318) 


1




 Solomon Mayer (0001689854) 


1




 Yehezkel Himelfarb (0001689912) 


1




 Yoav Waizer


1




 Yoseph Bornstein (0001690100) 


1











All related persons/companies# Filings





 ALPHA CAPITAL AKTIENGESELLSCHAFT


6




 ALPHA CAPITAL ANSTALT (0001140358) 


6




 ARDSLEY ADVISORY PARTNERS (0000900529) 


3




 ARIEL MANAGEMENT CORP


2




 Anson Funds Management LP (0001491072) 


1




 BJERKHOLT ERIC (0001197350) 


15




 Berkson Avram (0001690753) 


2




 Berkson Sandra (0001690757) 


2




 BlackRock Inc. (0001364742) 


3




 Bornstein Yoseph (0001690100) 


4




 Burell Scott R (0001399318) 


1




 CAPITAL VENTURES INTERNATIONAL (0001011712) 


2




 CAPITAL VENTURES INTERNATIONAL /E9/


2




 CRAIG STEWART (0001282810) 


15




 CYTOTHERAPEUTICS INC/DE (0000883975) 


903




 ENGLANDER ISRAEL A (0001017456) 


11




 Frigate Ventures LP (0001491072) 


2




 GABRIEL CAPITAL CORP (0001000242) 


2




 GENENTECH INC (0000318771) 


2




 GREER R SCOTT (0001211703) 


7




 Gadot Harel (0001690103) 


3




 Greenblock Capital, LLC (0001670457) 


1




 Himelfarb Yehezkel (0001689912) 


1




 ICS OPPORTUNITIES, LTD. (0001487118) 


2




 KOSHY GEORGE (0001257780) 


49




 LEVY RICARDO B (0000942916) 


18




 Lane Ventures, Inc. (0001691224) 


1




 Lewkowicz Leon (0001690590) 


9




 Lum Judi R (0001308210) 


5




 MCGLYNN MARTIN M (0001230631) 


41




 MERRILL LYNCH & CO INC (0000065100) 


4




 METROPOLITAN LIFE INSURANCE CO/NY (0000728618) 


1




 MILLENNIUM HOLDING GROUP LP (0001273089) 


11




 MILLENNIUM MANAGEMENT LLC (0001273087) 


14




 MILLENNIUM PARTNERS L P (0000851909) 


5




 Madden Martin J. (0001696864) 


1




 Massey Ian J (0001379281) 


4




 Naim David Ben (0001692130) 


1




 New BlackRock, Inc.


3




 OCONNELL DESMOND H JR (0001193615) 


4




 OFFMAN MAYER (0001180049) 


2




 PERLMUTTER ROGER M (0001184228) 


13




 PRICE T ROWE ASSOCIATES INC /MD/ (0000080255) 


2




 PUTNAM INVESTMENTS INC (0000766524) 


4




 RIVERVIEW GROUP LLC (0001273091) 


11




 SABBY MANAGEMENT, LLC (0001535610) 


3




 SCHIFFMAN GREGORY T (0001239011) 


8




 SCHIFFMAN GREOGRY T


8




 SCHWARTZ JOHN J (0001230629) 


23




 SCUDDER KEMPER INVESTMENTS INC (0000837581) 


1




 SCUDDER STEVENS & CLARK INC (0000837581) 


3




 STATE STREET RESEARCH ET AL (0000093758) 


1




 STEMCELLS INC (0000883975) 


846




 Salinas Eliseo Oreste (0001435756) 


2




 Shoham Moshe (0001690161) 


4




 Solomon Mayer (0001689854) 


1




 Stratton Kenneth Blair (0001461320) 


27




 TSUKAMOTO ANN (0001230632) 


42




 Technion Research & Development Foundation Ltd. (0001691391) 


2




 Trounson Alan O (0001618467) 


4




 WEISSMAN IRVING (0001230630) 


44




 Waizer Yoav Zvi (0001689845) 


1




 Young Rodney KB (0001337831) 


21







 








db
 
 


















































Himelfarb Yehezkel - StemCells Insider Transactions | TipRanks   





Go ProLogin / Sign Up Follow✓Get Real Time TransactionsInsider DetailsHimelfarb YehezkelStemCells (DEL_STEM)General Manager & COO Not RankedHimelfarb Yehezkel's PerformanceHimelfarb Yehezkel has not reported any informative transactions and therefore cannot be ranked.How are Insiders Ranked? Himelfarb Yehezkel's Trading Historybased on Form 4 Follow✓Get Real Time TransactionsCompany NameInsider PositionHolding ValueLast TransactionLast Transaction  AmountLast Transaction DateDEL_STEMStemCells--Himelfarb Yehezkel has not reported any informative transactions for DEL_STEM, therefore, performance cannot be measured.See All Insider Trading from Today >You May Also LikeMeet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.Related LinksHow can I benefit from Insider Trading? >See the Top 25 Corporate Insiders >Go to Hot Stocks by Insiders >Find which stocks Insiders traded today >Become a TipRanks MemberGet the best Investing Tips & Hacks straight to your emailFree MembershipSubmitInsider Trading Daily NewsletterProfessional day-trading strategy based on predictive insider transactionsAnnual Return: +85.42%Learn More >Powered by





























Yehezkel Himelfarb is now serving in a new position at Microbot Medical, Inc.


























































                      NEWS HOME
                    

Advertising
Board and Executive Moves
Energy
Health Care
Hedge Funds
M & A
Private Equity
Technology














        Yehezkel Himelfarb is now serving in a new position at Microbot Medical, Inc.    























































































































Email







LinkedIn







Facebook







Google+







Tweet







Reddit





Permalink



 

          Jan 3, 2017                         - RelSci Data Update                

          Board and Executive Moves      




Background Information:


Yehezkel Himelfarb »
Chief Operating Officer & General Manager at Microbot Medical, Inc.


Career:




                                                                Microbot Medical, Inc.                                                            







                                                                IceCure Medical Ltd.                                                            







                                                                Remon Medical Technologies, Inc.                                                            





Boards:




                                                                IceCure Medical Ltd.                                                            





Education:




                                                                Tel Aviv University                                                            







In The News:




                            Yehezkel Himelfarb is no longer serving in their position at IceCure Medical Ltd.                            


                            January 3, 2017  •  RelSci                        





                            Microbot Medical Appoints Hezi Himelfarb as General Manager and Chief Operating Officer                            


                            December 6, 2016  •  GlobeNewswire                        





                            National Multi-Center Clinical Trial of Non-Surgical Breast Cancer Treatment Enrolls First Patients                            


                            October 21, 2014  •  PR Newswire                        









Yehezkel Himelfarb »
Chief Operating Officer & General Manager at Microbot Medical, Inc.






Career:

•


                                                                                    Microbot Medical, Inc.                                                                                    



•


                                                                                    IceCure Medical Ltd.                                                                                    



•


                                                                                    Remon Medical Technologies, Inc.                                                                                    




Boards:

•


                                                                                    IceCure Medical Ltd.                                                                                    




Education:

•


                                                                                    Tel Aviv University                                                                                    







In The News:




 


                                                    Yehezkel Himelfarb is no longer serving in their position at IceCure Medical Ltd.                                                





                                     January 3, 2017  •  RelSci                                





 


                                                    Microbot Medical Appoints Hezi Himelfarb as General Manager and Chief Operating Officer                                                





                                     December 6, 2016  •  GlobeNewswire                                





 


                                                    National Multi-Center Clinical Trial of Non-Surgical Breast Cancer Treatment Enrolls First Patients                                                





                                     October 21, 2014  •  PR Newswire                                








Microbot Medical, Inc. »
Microbot Medical, Inc. engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Its carries out its operations through the ViRob and TipCat paltforms. The company's ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt (SCS), a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid (CSF) shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCAT platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. It is developed for use in colonoscopy procedures. The company was founded by Harel Gadot, Moshe Shoham, and Yossi Bornstein in 2010, and is headquartered in Hingham, MA.




In The News:




                            Global Regenerative Medicine Market Analysis & Forecast 2017-2021 - Research and Markets                            


                            May 5, 2017  •  PR Newswire                        





                            Regenerative Medicine Market Growing at $53.7 Billion by 2021 Says a New Report at ReportsnReports.com                            


                            May 1, 2017  •  PR Newswire                        





                            World Patent Ratings Releases Details of Conference Call on Transparency and Intangible Asset Valuation in the Biotechnology Industry                             


                            January 3, 2017  •  ICT Monitor Worldwide                        









Microbot Medical, Inc. »
Microbot Medical, Inc. engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Its carries out its operations through the ViRob and TipCat paltforms. The company's ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt (SCS), a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid (CSF) shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCAT platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. It is developed for use in colonoscopy procedures. The company was founded by Harel Gadot, Moshe Shoham, and Yossi Bornstein in 2010, and is headquartered in Hingham, MA.






In The News:




 


                                                    Global Regenerative Medicine Market Analysis & Forecast 2017-2021 - Research and Markets                                                





                                     May 5, 2017  •  PR Newswire                                





 


                                                    Regenerative Medicine Market Growing at $53.7 Billion by 2021 Says a New Report at ReportsnReports.com                                                





                                     May 1, 2017  •  PR Newswire                                





 


                                                    World Patent Ratings Releases Details of Conference Call on Transparency and Intangible Asset Valuation in the Biotechnology Industry                                                 





                                     January 3, 2017  •  ICT Monitor Worldwide                                















You've found a premium RelSci Pro feature!



Connect to Individuals and Organizations In This Story

Upgrade to RelSci Pro to easily sync your contacts and see how you can reach the people and organizations featured in this article.


Start My Free Trial  ➤

Still not convinced? Check out our full listing of features here.



Not Now










Are you a RelSci Pro Subscriber?

Login to RelSci Pro 
                        ➤


Not a Pro Subscriber? Log in here to manage your alerts









 Keep me signed in.
        

Login  ➤



        Forgot your Password?
    

























 I have read the LexisNexis terms & conditions




Sign Me Up  ➤













